Device type · DAP
Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
DAP
Hematology
Device class
Class II
FDA decisions since 2015
5
510(k), De Novo and PMA
Adverse event reports
3
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
- Product code
- DAP
- Device class
- Class II
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7320
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DAP
Latest FDA decisions
Siemens Healthcare Diagnostic Products GmbH
K253985 · Decided Aug 11, 2026 · 242 days after receipt
Device type: Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (DAP) · Laboratory Medicine & Pathology
- HemosIL D-Dimer HS 500510(k)
K172903 · Decided Nov 22, 2017 · 61 days after receipt
Device type: Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (DAP) · Laboratory Medicine & Pathology
- STA® - Liatest® D-Di510(k)
K162227 · Decided Dec 10, 2016 · 124 days after receipt
Device type: Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (DAP) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
Reports received
3
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
3
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 1 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 1 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 1 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 1 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- False Negative Result2
- Non Reproducible Results1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions3
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1585-2026 · Started Feb 5, 2026 · Posted by FDA Mar 19, 2026
Reason given: After receiving customer complaints, investigations confirmed the presence of a positive bias in D-Dimer measurements throughout the entire analytical range.
Cause as FDA categorized it: Process change control
- D-Dimer TestOpen, Classified
Z-0731-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025
Reason given: Distribution without premarket approval/clearance.
Cause as FDA categorized it: No Marketing Application
- Product: STA Liatest D-Di; REF: 00515;Open, Classified
Z-0205-2026 · Started Sep 12, 2025 · Posted by FDA Oct 16, 2025
Reason given: A potential risk of underestimation of D-Dimer (D-Di) levels with the two listed lots.
Cause as FDA categorized it: Under Investigation by firm
10 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.